On November 18, 2024, Katherine Stueland, the CEO of GeneDx Holdings Corp, executed a sale of 45,415 shares of the company. Following this transaction, the insider now holds 60,011 shares of GeneDx Holdings Corp. The details of this transaction can be found in the SEC Filing.
GeneDx Holdings Corp (WGS, Financial) is a company that specializes in providing genomic testing and analysis services. The company focuses on delivering comprehensive genetic insights to support healthcare providers in diagnosing and managing complex genetic conditions.
Over the past year, Katherine Stueland has sold a total of 103,434 shares and has not made any purchases. The insider transaction history for GeneDx Holdings Corp indicates a trend of 5 insider buys and 42 insider sells over the same period.
On the day of the recent sale, shares of GeneDx Holdings Corp were trading at $70.41, giving the stock a market cap of $1.951 billion. The stock's GF Value is estimated at $12.62, resulting in a price-to-GF-Value ratio of 5.58. This suggests that the stock is significantly overvalued based on its GF Value.
The GF Value is an intrinsic value estimate developed by GuruFocus, calculated using historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow. It also incorporates a GuruFocus adjustment factor based on the company’s past returns and growth, along with future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
